COMMUNIQUÉS West-GlobeNewswire
-
InnoCare Announces First Healthy Volunteer Dosed in Clinical Trial of Novel VAV1 Degrader ICP-538 in China
16/03/2026 -
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
15/03/2026 -
Pittsburgh Aesthetics Rebrands as Avere Beauty, Expanding Med Spa Services in Mars, Pennsylvania and Surrounding Areas
16/03/2026 -
Be Well OC Launches “Red Tape” Campaign Calling for Full Access to Behavioral Health Campuses
15/03/2026 -
En 2025, le KFSH s’est classé au premier rang mondial pour le nombre de transplantations rénales croisées réalisées au sein d’un centre unique
14/03/2026 -
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
14/03/2026 -
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
14/03/2026 -
AgelessRx 2026: Longevity Telehealth Platform Overview — Treatments, Pricing, Compounded Medications, and What Prospective Patients Should Know
14/03/2026 -
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
13/03/2026 -
Publication relating to transparency notification
13/03/2026 -
Vanish DrySerum Nanofiber Acne Mask Claims Evaluated: 2026 Consumer Research Report Examining Barrier Repair Technology, Ingredient Research, and What Consumers Should Verify Before Buying
14/03/2026 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
13/03/2026 -
Publication relative à une notification de transparence
13/03/2026 -
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
13/03/2026 -
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
13/03/2026 -
Ipsen - Février 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
13/03/2026 -
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13/03/2026 -
How Scientists Measure the Circulation You Actually Feel — Not Just the Arteries They Can See
13/03/2026 -
ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases
13/03/2026
Pages